These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 16268514

  • 1. [Preparation of silymarin proliposomes and its pharmacokinetics in rats].
    Xiao YY, Song YM, Chen ZP, Ping QN.
    Yao Xue Xue Bao; 2005 Aug; 40(8):758-63. PubMed ID: 16268514
    [Abstract] [Full Text] [Related]

  • 2. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs.
    Yan-yu X, Yun-mei S, Zhi-peng C, Qi-neng P.
    Int J Pharm; 2006 Aug 17; 319(1-2):162-8. PubMed ID: 16687221
    [Abstract] [Full Text] [Related]

  • 3. [Preparation of self-assemble nobiletin proliposomes and its pharmacokinetics in rats].
    Lin W, Yao J, Zhou JP.
    Yao Xue Xue Bao; 2009 Feb 17; 44(2):192-6. PubMed ID: 19408692
    [Abstract] [Full Text] [Related]

  • 4. [Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles].
    He J, Hou SX, Feng JF, Cai BQ.
    Zhongguo Zhong Yao Za Zhi; 2005 Nov 17; 30(21):1651-3. PubMed ID: 16400939
    [Abstract] [Full Text] [Related]

  • 5. [Studies on preparation of recombinant hirudin-2 liposome and its pharmacokinetics by nasal delivery in rats].
    Zhang YJ, Wang XL, Wu JM, Cheng MX.
    Zhongguo Zhong Yao Za Zhi; 2007 May 17; 32(9):801-4. PubMed ID: 17639978
    [Abstract] [Full Text] [Related]

  • 6. Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits.
    Xu H, He L, Nie S, Guan J, Zhang X, Yang X, Pan W.
    J Control Release; 2009 Nov 16; 140(1):61-8. PubMed ID: 19651165
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Freeze-drying of silymarin-loaded solid lipid nanoparticles (SM-SLN)].
    He J, Feng JF, Zhang LL, Lu WG, Hou SX.
    Zhongguo Zhong Yao Za Zhi; 2005 Jan 16; 30(2):110-2. PubMed ID: 15714812
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Influence factors on the entrapment of drugs in a novel proliposomes].
    Wang M, Gao XL.
    Yao Xue Xue Bao; 2006 Dec 16; 41(12):1204-7. PubMed ID: 17290623
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation.
    El-Samaligy MS, Afifi NN, Mahmoud EA.
    Int J Pharm; 2006 Feb 03; 308(1-2):140-8. PubMed ID: 16356669
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
    Qiang F, Shin HJ, Lee BJ, Han HK.
    Int J Pharm; 2012 Jul 01; 430(1-2):161-6. PubMed ID: 22525082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.